Divi's Laboratories Hyderabad
GPTKB entity
Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Murali Divi
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedBy |
Murali Divi
|
| gptkbp:foundedYear |
1990
|
| gptkbp:headquartersLocation |
gptkb:Hyderabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
Divi's Laboratories Hyderabad
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:ISIN |
INE361B01024
|
| gptkbp:marketCap |
over $10 billion
|
| gptkbp:notableInstitution |
Unit I, Hyderabad
Unit II, Visakhapatnam |
| gptkbp:numberOfEmployees |
over 15,000
|
| gptkbp:products |
Active pharmaceutical ingredients
Intermediates |
| gptkbp:publiclyTraded |
Yes
|
| gptkbp:revenueFY2023 |
over ₹8,900 crore
|
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:website |
https://www.divislabs.com/
|
| gptkbp:主要业务 |
Custom synthesis
Generic APIs |
| gptkbp:bfsParent |
gptkb:Madhapur,_Hyderabad
|
| gptkbp:bfsLayer |
7
|